# McKesson acquisition of Precision Medicine Group

> Live situation record from CLSTR: https://clstr.news/situations/mckesson-acquisition-of-precision-medicine-group
> Updated: 2026-08-28T08:12:03.000Z. Sources: 7. Developments: 2.

McKesson Corporation has agreed to acquire Precision Medicine Group, LLC, for approximately $2.25 billion. The acquisition is intended to bolster McKesson’s clinical research and biopharmaceutical commercialization capabilities, specifically within its oncology and multi-specialty segment.

Precision Medicine Group provides various services to biotechnology and pharmaceutical companies, including biomarker intelligence, laboratory services, market access consulting, and global clinical research organization capabilities. The transaction remains subject to regulatory approvals.

## Timeline

### 2026-08-28: McKesson to acquire Precision Medicine Group for US$2.25 billion

McKesson has agreed to acquire Precision Medicine Group for US$2.25 billion to expand its clinical research and biopharmaceutical commercialization services.

4 sources. https://clstr.news/cluster/mckesson-to-acquire-precision-medicine-group-for-us225-billion

### 2026-08-25: Lundbeck and McKesson announce major pharma industry developments

Lundbeck and EVERSANA are partnering to scale AI-driven commercialization, while McKesson has agreed to acquire Precision Medicine Group for $2.25 billion.

3 sources. https://clstr.news/cluster/lundbeck-and-mckesson-announce-major-pharma-industry-developments

---
Cite as: McKesson acquisition of Precision Medicine Group. CLSTR, https://clstr.news/situations/mckesson-acquisition-of-precision-medicine-group